Contineum Therapeutics, Inc. (CTNM)
$13.38+1.52%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $500M
- Beta
- 0.75
- P/E (TTM)
- -7.31
- Short % float
- 11.05%
- Days to cover
- 3.6
- SI change
- +25.5%
- 1W
- +1.98%
- 1M
- -8.73%
- vs SPY 1W
- +0.82%
- vs SPY 1M
- -11.72%
Industry peers
FMP comparable companies · ranked by market cap
- RAPPSELLRapport Therapeutics, Inc. Common Stock$1.4BCRISISQ 26$29.85+2.68%
- GHRSSELLGH Research PLC$1.4BCRISISQ 16$20.45+3.23%
- LBRXSELLLB Pharmaceuticals Inc Common Stock$992MCRISISQ 80$34.61+7.54%
- SPTXSELLSeaport Therapeutics, Inc. Common Stock$959MQ -0$17.91+1.34%
- ANROSELLAlto Neuroscience, Inc.$843MCRISISQ 17$24.03+1.41%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 16
- VALUE
- 7
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-14.8%
REV YoY-
ROE-24.7%
EPS YoY-
ROA-23.0%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-7.31
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B1.98
P/FCF-
EV/EBITDA-7.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.74
ALTMAN Z-
CURR RATIO37.17
ND/EBITDA-
BETA0.75
